Technology Networks spoke with Russell Monson, Professor of Ecology and Evolutionary Biology at the University of Arizona, to learn more about a recent study in which poplar trees were genetically modified to not harm air quality.
Historically, efforts to target the substance P (SP) neurokinin 1 receptor (NK1R), for the treatment of pain have failed. These studies had one critical flaw, whilst they were targeting the right receptor, they were focusing on the wrong location.READ MORE
If you want to build a foundational understanding of genomics in both health and disease, it's important to be able to distinguish between the different type of genetic mutations that can occur. Here, we take a look at some of the mutations that can be encountered and the impact they have on the genome.READ MORE
In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.READ MORE
You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.READ MORE
In epidemiology, prevalence and incidence are among the most fundamental measures when it comes to monitoring disease. But do you know what they mean or how and why they are important? This article takes a look at disease prevalence and incidence, what this information tells us and how it can be used.READ MORE
Looking for new materials that make photovoltaic solar cells more efficient is a challenge that has taxed current supercomputing resources to the max. That’s why a number of academic institutions hope to utilize Aurora, the forthcoming exascale computer at the U.S. Department of Energy’s (DOE) Argonne National Laboratory, to further their research.READ MORE
Liquid biopsies are tests conducted on blood samples that examine biomarkers shed by tumors, such as cancer cells or pieces of tumor DNA. The data from liquid biopsies can be used in place of or alongside that of traditional surgical biopsies. In this article, we review the theory behind liquid biopsies and their applications in cancer medicine.
Technology Networks Explores the CRISPR Revolution: An Interview With Livestock Geneticist Alison Van EenennaamArticle
The final instalment of Technology Networks Explores the CRISPR Revolution is an interview with Dr Alison Van Eenennaam, a livestock geneticist based at the University of California. The focus of her laboratory's research is the utilization of DNA-based biotechnologies in the production of beef cattle and in agricultural systems.READ MORE